शोधकर्ताओं की एक अंतरराष्ट्रीय टीम ने पाया कि कोलेस्ट्रॉल कम करने वाली दवा दिल के दौरे और स्ट्रोक के उच्च जोखिम वाले लोगों की रक्षा करने का एक अधिक प्रभावी और सुविधाजनक तरीका हो सकती है।

ऑस्ट्रेलिया में मोनाश विश्वविद्यालय के शोधकर्ताओं के नेतृत्व में किए गए अध्ययन में ओबिसेट्रैपिब नामक एक बार दैनिक मौखिक दवा का परीक्षण किया गया और पाया गया कि यह एलडीएल या खराब कोलेस्ट्रॉल और लिपोप्रोटीन (ए), [एलपी (ए)] - हृदय रोग के दो प्रमुख योगदानकर्ताओं को काफी हद तक कम करती है।

मोनाश विश्वविद्यालय के विक्टोरियन हार्ट इंस्टीट्यूट के निदेशक, अध्ययन के प्रमुख प्रोफेसर स्टीफन निकोल्स ने कहा कि निष्कर्ष उन रोगियों के लिए एक महत्वपूर्ण कदम है, जो वर्तमान उपचारों के साथ अपने कोलेस्ट्रॉल लक्ष्य तक पहुँचने के लिए संघर्ष कर रहे हैं।

निकोलस ने कहा, "हम जानते हैं कि दिल के दौरे या स्ट्रोक के उच्च जोखिम वाले कई लोग अपने कोलेस्ट्रॉल के स्तर को पर्याप्त रूप से कम नहीं कर पाते हैं, यहाँ तक कि सबसे अच्छे उपलब्ध उपचारों के साथ भी।"

An international team of researchers found that a cholesterol-lowering drug may offer a more effective and convenient way to protect people at high risk of heart attack and stroke.

The study led by researchers at Monash University in Australia tested a once-daily oral medication called Obicetrapib and found it significantly lowered both LDL or bad cholesterol and lipoprotein(a), [Lp(a)] -- two key contributors to cardiovascular disease.

The findings marked an important step forward for patients who have struggled to reach their cholesterol targets with current therapies, said study lead Professor Stephen Nicholls, Director of Monash University's Victorian Heart Institute.

"We know that many people at high risk of heart attack or stroke don't get their cholesterol levels low enough, even on the best available treatments," Nicholls said.

"Obicetrapib offers a promising new option-not only did it lower LDL cholesterol by over 30 per cent, but we also saw a reduction in Lp(a), which is much harder to treat and has been linked to increased heart disease risk," he added.

India is witnessing a significant uptick in the adoption of diagnostic radiology devices, with a major rise in accelerated adoption of AI-powered technologies and remote monitoring solutions, according to a report on Friday.

The report by 1Lattice, a tech-enabled market intelligence firm, also attributed the growth to rising disease burden, increased investment in healthcare infrastructure.

It revealed that India has registered 1.48 lakh radiology devices, with Maharashtra (20,590), Tamil Nadu (15,267), and Uttar Pradesh (12,236) leading the charge.

A new study by researchers at the US National Institutes of Health (NIH) has revealed a concerning rise in the incidence of several cancer types among individuals under age 50 in the country between 2010 and 2019.

According to the findings, published in the journal Cancer Discovery, the incidence of 14 out of 33 analysed cancer types increased in at least one younger age group,” news agency reported.

Notably, common cancers such as female breast, colorectal, kidney, and uterine cancers saw marked increases, with some of these also rising among older adults.

"This study provides a starting point for understanding which cancers are increasing among individuals under age 50," said lead investigator Meredith Shiels, from NIH's National Cancer Institute.

A woman in Kerala's Malappuram on Thursday tested positive for Nipah, the deadly zoonotic virus that causes infections in human beings and is time and again striking in and around the district in the past few years, officials said.

The 42-year-old woman had been suffering from fever and Nipah-related symptoms for a while.

According to the officials, the first two tests done at a Kozhikode government laboratory came out negative, but with no respite in her health condition, a third test turned positive.

Soon, the sample was sent to the virology laboratory in Pune, and the result, received on Thursday, came out positive.

The woman is now admitted to a hospital in Perinthalmanna near here and has been isolated for a while.

On the occasion of World Thalassemia Day, doctors and health experts at Paras Health, Panchkula, are calling attention to the urgent need for increased awareness, early screening, and improved access to treatment for thalassemia in India.
Thalassemia, a genetic blood disorder caused by abnormal hemoglobin production, continues to pose a major public health challenge. India carries nearly 25% of the global β-thalassemia burden, with approximately 100,000 patients and an estimated 42 million carriers.

Eating a diet rich in vegetables, legumes, and whole grains in childhood can delay the onset of menstruation in girls, according to a new study.

The findings, published in the journal Human Reproduction remained unaltered by the girls’ body mass index (BMI) or height, both of which have been associated with the earlier onset of periods.

The study has implications for health in later life as it is well known that women who started their periods at an early age may be at higher risk for diabetes, obesity, breast cancer, and diseases of the heart and blood vessels.

“I think our findings highlight the need for all children and adolescents to have access to healthy meal options and the importance of school-based breakfasts and lunches being based on evidence-based guidelines,” said Holly Harris, Associate Professor at the Fred Hutchinson Cancer Center in Seattle, US.

Nearly one out of five women and one out of seven men aged 20, and older globally experienced sexual violence by age 15 or even younger, according to a study published in the journal The Lancet on Thursday.

The research from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School of Medicine in Seattle, US, showed that 67 per cent of females and 72 per cent of males reported being first sexually abused during childhood, before the age of 18.

Almost 42 per cent of females and approximately 48 per cent of males said their first sexual violence incident occurred before the age of 16. Alarmingly, 8 per cent of female survivors and 14 per cent of male survivors reported being first exposed to sexual violence before 12.

“Sexual violence against children is a widespread human rights and public health issue, and the world is clearly failing to end it,” said senior author Dr. Emmanuela Gakidou, Professor at IHME.

Israeli researchers have identified a genetic "fingerprint" that helps predict the effectiveness of immunotherapy treatments, according to a study.

The study, by the Israel Institute of Technology (Technion), stated that the discovery would help improve the personalisation of immunotherapy treatments, news agency reported.

Immunotherapy is considered to be one of the greatest revolutions in cancer treatment. It enhances the immune system’s ability to target and destroy cancer cells efficiently.

However, a major challenge in immunotherapy is the unpredictability of patient responses. Some patients do not benefit and may experience side effects without significant improvement.

Therefore, there is a need to identify biomarkers that can forecast the effectiveness of treatment based on the specific data of each patient.

In their study, published in the journal Cell Genomics, the team examined the genetic characteristics of T-cell clones -- groups of multiplied immune T cells that specialise in targeting a specific threat once recognised -- and their influence on treatment success.

The independent Oversight Board on Wednesday has sought opinion of general public to restore or remove child abuse videos on Meta.

The Board, an independent body of 22 global human rights and freedom of expression experts from across the political spectrum and the world, is reviewing two videos which show teachers hitting children in school settings.

“The review will explore the key tension between sharing content depicting non-sexual child abuse to shed light on wrongdoing and demand accountability, and the need to protect children's safety, dignity, and privacy,” the Board said in a statement.